Insider Trading & Ownership - Denali Therapeutics Inc. (DNLI)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Denali Therapeutics Inc.
Goto Prev, 0, 1, 2, 3, 4, 5, 6, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2022-08-19
Sale		 2022-08-23
4:45 pm		 Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer		 2,576 $33.22 $85,575 303,684
(Indirect
Direct)		 View
2022-07-25
Sale		 2022-07-27
6:49 pm		 Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director		 20,000 $35.61 $712,110 2,187,225
(Indirect
Direct)		 View
2022-03-23
Sale(A)		 2022-06-28
3:07 pm		 Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director		 20,000 $33.83 $676,583 2,261,239
(Indirect
Direct)		 View
2022-06-23
Sale		 2022-06-27
8:54 pm		 Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director		 60,000 $30.72 $1,843,045 2,207,225
(Indirect
Direct)		 View
2022-03-23
Sale		 2022-03-25
5:57 pm		 Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director		 20,000 $33.83 $676,583 2,261,239
(Indirect
Direct)		 View
2022-02-11
Sale		 2022-02-15
6:58 pm		 Denali Therapeutics Inc. DNLI Watts Ryan J.
President and CEO		 9,491 $34.72 $329,528 2,370,591
(Indirect
Direct)		 View
2022-02-11
Sale		 2022-02-15
6:56 pm		 Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO and Treasurer		 2,560 $34.69 $88,806 970,221
(Indirect
Direct)		 View
2022-02-11
Sale		 2022-02-15
6:55 pm		 Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO and Secretary		 2,803 $34.68 $97,208 563,465
(Indirect
Direct)		 View
2022-02-11
Sale		 2022-02-15
6:53 pm		 Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer		 2,918 $34.71 $101,284 283,760
(Indirect
Direct)		 View
2022-02-09
Sale		 2022-02-11
5:20 pm		 Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO and Treasurer		 1,296 $37.09 $48,073 972,781
(Indirect
Direct)		 View
2022-02-09
Sale		 2022-02-11
5:19 pm		 Denali Therapeutics Inc. DNLI Watts Ryan J.
President and CEO		 2,719 $37.55 $102,104 2,380,082
(Indirect
Direct)		 View
2022-02-09
Sale		 2022-02-11
5:18 pm		 Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO and Secretary		 1,423 $37.1 $52,800 566,268
(Indirect
Direct)		 View
2022-02-09
Sale		 2022-02-11
5:16 pm		 Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer		 1,423 $37.1 $52,791 286,678
(Indirect
Direct)		 View
2022-01-05
Sale		 2022-01-07
6:06 pm		 Denali Therapeutics Inc. DNLI Watts Ryan J.
President and CEO		 5,007 $44.78 $224,213 2,312,052
(Indirect
Direct)		 View
2022-01-05
Sale		 2022-01-07
6:06 pm		 Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO and Treasurer		 2,225 $44.75 $99,569 974,077
(Indirect
Direct)		 View
2022-01-05
Sale		 2022-01-07
6:05 pm		 Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer		 2,845 $44.78 $127,399 288,101
(Indirect
Direct)		 View
2022-01-05
Sale		 2022-01-07
6:05 pm		 Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO and Secretary		 2,846 $44.77 $127,415 567,691
(Indirect
Direct)		 View
2021-12-28
Sale		 2021-12-30
9:59 pm		 Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director		 63,131 $44.43 $2,805,197 2,323,218
(Indirect
Direct)		 View
2021-12-06
Sale		 2021-12-08
5:35 pm		 Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO and Secretary		 10,000 $42.27 $422,736 539,537
(Indirect
Direct)		 View
2021-12-06
Sale		 2021-12-08
5:35 pm		 Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer		 1,476 $42.52 $62,760 259,946
(Indirect
Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2022-08-09
Option Award		 2022-08-11
7:22 pm		 N/A
N/A		 Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer		 22,500 $0 306,260
(Direct)		 View
2022-08-09
Option Award		 2022-08-11
7:21 pm		 N/A
N/A		 Denali Therapeutics Inc. DNLI Schuth Alexander O.
COFO and Secretary		 22,500 $0 586,505
(Direct)		 View
2022-07-19
Exercise		 2022-07-21
7:36 pm		 N/A
N/A		 Denali Therapeutics Inc. DNLI Krognes Steve E.
Director		 62,500 $0.68 1,001,721
(Direct)		 View
2022-07-19
Exercise		 2022-07-21
7:36 pm		 2022-07-19
2022-08-01		 Denali Therapeutics Inc. DNLI Krognes Steve E.
Director		 62,500 $0 1,001,721
(Direct)		 View
2022-06-02
Option Award		 2022-06-06
8:09 pm		 N/A
2032-06-02		 Denali Therapeutics Inc. DNLI Schenkein David P
Director		 23,945 $0 86,736
(Direct)		 View
2022-06-02
Option Award		 2022-06-06
8:09 pm		 N/A
2032-06-02		 Denali Therapeutics Inc. DNLI Klein Peter S
Director		 23,945 $0 29,272
(Direct)		 View
2022-06-02
Option Award		 2022-06-06
8:09 pm		 N/A
2032-06-02		 Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director		 23,945 $0 2,285,184
(Direct)		 View
2022-06-02
Option Award		 2022-06-06
8:09 pm		 N/A
2032-06-02		 Denali Therapeutics Inc. DNLI Cole Douglas G.
Director		 23,945 $0 40,307
(Direct)		 View
2022-06-02
Option Award		 2022-06-06
8:08 pm		 N/A
2032-06-02		 Denali Therapeutics Inc. DNLI SATO VICKI L
Director		 23,945 $0 160,108
(Direct)		 View
2022-06-02
Option Award		 2022-06-06
8:08 pm		 N/A
2032-06-02		 Denali Therapeutics Inc. DNLI Cook Jennifer E.
Director		 23,945 $0 29,272
(Direct)		 View
2022-06-02
Option Award		 2022-06-06
8:07 pm		 N/A
2032-06-02		 Denali Therapeutics Inc. DNLI FLATLEY JAY T
Director		 23,945 $0 354,272
(Direct)		 View
2022-06-02
Option Award		 2022-06-06
8:07 pm		 N/A
2032-06-02		 Denali Therapeutics Inc. DNLI Thornberry Nancy
Director		 23,945 $0 26,456
(Direct)		 View

Ownership		 2022-02-17
8:25 pm		 N/A
N/A		 Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director		 0 $0 2,281,239
(Indirect)		 View
2021-12-13
Ownership		 2022-02-17
8:25 pm		 N/A
N/A		 Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director		 200,000 $0 2,281,239
(Direct)		 View
2022-02-10
Exercise		 2022-02-11
5:19 pm		 N/A
N/A		 Denali Therapeutics Inc. DNLI Watts Ryan J.
President and CEO		 6,118 $9.6 2,380,082
(Direct)		 View
2022-02-10
Exercise		 2022-02-11
5:19 pm		 N/A
2027-03-07		 Denali Therapeutics Inc. DNLI Watts Ryan J.
President and CEO		 70,749 $0 2,380,082
(Direct)		 View
2022-02-10
Exercise		 2022-02-11
5:19 pm		 N/A
N/A		 Denali Therapeutics Inc. DNLI Watts Ryan J.
President and CEO		 64,631 $5.28 2,380,082
(Direct)		 View
2022-02-03
Option Award		 2022-02-07
6:54 pm		 N/A
2032-02-03		 Denali Therapeutics Inc. DNLI Harris Erik
Director		 27,476 $0 27,476
(Direct)		 View
2022-01-08
Option Award		 2022-01-11
7:54 pm		 N/A
N/A		 Denali Therapeutics Inc. DNLI Thornberry Nancy
Director		 627 $0 2,511
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
7:04 pm		 N/A
2032-01-02		 Denali Therapeutics Inc. DNLI Schuth Alexander O.
COO and Secretary		 124,000 $0 663,537
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
7:03 pm		 N/A
2032-01-02		 Denali Therapeutics Inc. DNLI Ho Carole
Chief Medical Officer		 124,000 $0 383,946
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
7:03 pm		 N/A
2032-01-02		 Denali Therapeutics Inc. DNLI Watts Ryan J.
President and CEO		 248,500 $0 2,503,559
(Direct)		 View
2022-01-03
Option Award		 2022-01-05
7:03 pm		 N/A
2032-01-02		 Denali Therapeutics Inc. DNLI Krognes Steve E.
CFO and Treasurer		 124,000 $0 1,069,302
(Direct)		 View
2021-10-04
Gift		 2021-12-30
9:59 pm		 N/A
N/A		 Denali Therapeutics Inc. DNLI Tessier-Lavigne Marc
Director		 400,000 $0 2,323,218
(Direct)		 View
(A) Indicate amendment filing.
Goto Prev, 0, 1, 2, 3, 4, 5, 6, Next